BACKGROUND: We have analyzed our experience with differentiated thyroi
d cancer patients with extrathyroidal extension (ETE) to investigate p
atterns of recurrence and define factors that predict failure. PATIENT
S AND METHODS: The records of 1,012 patients treated surgically from 1
930 to 1985 were reviewed. A total of 79 patients (8%) had ETE, The me
dian length of follow-up was 10 years. RESULTS: Patients with ETE were
more likely to fail treatment and to die of their disease than were p
atients without ETE (77% versus 34% and 71% versus 13%, respectively;
P < 0.0001), Local, regional, and distant failures were more prominent
among patients with ETE than among those without ETE (48% versus 9%,
41% versus 16%, and 37% versus 11% respectively; P < 0.0001) Survival
of patients with ETE was adversely affected by nonpapillary histology,
distant metastasis, age > 45, tumor size > 4 cm, and incomplete excis
ion (P less than or equal to 0.05), After stratification for age, surv
ival in older patients was not affected by tumor size or incomplete ex
cision, while in younger patients tumor size or the presence of distan
t metastasis did not adversely affect survival. Patients younger than
45 with negative margins had similar survival to patients without ETE
(P = 0.46). CONCLUSIONS: Patients with ETE are move likely to die of t
heir disease and to fail at all sites, Survival in older patients was
not affected by incomplete excision while it was in younger patients,
The presence of distant metastasis did not affect survival in younger
patients. Our results suggest that among patients under 45, the presen
ce of ETE does not adversely impact upon survival when the primary tum
or is completely resected.